ログイン
言語:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

  1. 学位論文
  2. 博士論文(医学)

Synergistic induction of apoptosis by mapatumumab and anthracyclines in human bladder cancer cells

https://kagawa-u.repo.nii.ac.jp/records/235
https://kagawa-u.repo.nii.ac.jp/records/235
ba50673d-7704-426e-9fc8-fe7862ec2909
名前 / ファイル ライセンス アクション
Med_A603.pdf 本文 (1.7 MB)
Med_A603_abstract.pdf 内容の要旨 (64.3 kB)
Med_A603_result.pdf 審査の結果の要旨 (86.4 kB)
Item type 学位論文 / Thesis or Dissertation(1)
公開日 2019-07-31
タイトル
タイトル Synergistic induction of apoptosis by mapatumumab and anthracyclines in human bladder cancer cells
言語 en
言語
言語 eng
資源タイプ
資源タイプ識別子 http://purl.org/coar/resource_type/c_db06
資源タイプ doctoral thesis
アクセス権
アクセス権 open access
アクセス権URI http://purl.org/coar/access_right/c_abf2
著者 Ahmed, Syed Minhaj Uddin

× Ahmed, Syed Minhaj Uddin

ja Ahmed, Syed Minhaj Uddin

en Ahmed, Syed Minhaj Uddin

Search repository
抄録
内容記述タイプ Abstract
内容記述 Abstract
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) triggers apoptosis in a variety of tumor cells by engaging the death receptors 4 (DR4) and 5 (DR5). We investigated the effect of chemotherapeutic drugs on DR4-mediated apoptosis in human bladder cancer cells, using a human monoclonal agonistic antibody specific for DR4, mapatumumab. Cytotoxicity was determined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. Synergy was assessed by isobolographic analysis. Treatment of human bladder cancer T24 cells with mapatumumab in combination with mitomycin C, vinblastine or gemcitabine did not overcome resistance to these agents. However, treatment with mapatumumab in combination with epirubicin (EPI) had a synergistic cytotoxic effect. Synergy was also obtained in KU7 and RT112 human bladder cancer cells. A synergistic effect was also observed with mapatumumab in combination with pirarubicin. The synergy obtained in cytotoxicity with mapatumumab and EPI was also achieved in apoptosis. EPI markedly increased DR4 expression in the bladder cancer cells at both the mRNA and protein levels. Furthermore, the combination-induced cytotoxicity was significantly suppressed by the DR4:Fc chimeric protein. The combination of EPI and mapatumumab significantly activated the caspase cascade, including caspase-8, -9 and -3, which are the downstream molecules of death receptors. These findings indicate that EPI sensitizes bladder cancer cells to DR4-mediated apoptosis through induction of DR4 and activation of caspases, suggesting that the combination therapy of EPI and mapatumumab may be effective for bladder cancer therapy.
言語 en
学位名
言語 ja
学位名 博士(医学)
学位授与機関
識別子Scheme kakenhi
識別子 16201
言語 ja
機関名 香川大学
言語 en
機関名 Kagawa University
学位授与年月日
学位授与年月日 2015-03-24
学位授与番号
学位授与番号 甲第603号
論文ID(NAID)
識別子タイプ NAID
関連識別子 500001358799
PubMed番号
識別子タイプ PMID
関連識別子 25483927
関連サイト
関連タイプ isVersionOf
識別子タイプ DOI
関連識別子 https://doi.org/10.3892/or.2014.3654
関連サイト
関連タイプ isIdenticalTo
識別子タイプ URI
関連識別子 https://dl.ndl.go.jp/pid/11344363
著者版フラグ
出版タイプ P
出版タイプResource http://purl.org/coar/version/c_fa2ee174bc00049f
KEID
27642
戻る
0
views
See details
Views

Versions

Ver.1 2023-05-15 10:19:39.264392
Show All versions

Share

Mendeley Twitter Facebook Print Addthis

Cite as

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR 2.0
  • OAI-PMH JPCOAR 1.0
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX

Confirm


Powered by WEKO3


Powered by WEKO3